get a key
steadybase-$ company LXEO
account_id none on file
legal_name Lexeo Therapeutics, Inc.
ticker LXEO
cik 1907108
domain lexeotx.com
entry_point_account_id none on file
name Lexeo Therapeutics Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 19 executives 3 family 0
why_nownone on file
callsnone on file
filings
In connection with the Company’s lease of office space and laboratory space, the Company provided a security deposit to the landlord in the form of a letter of credit totaling $ 1.2 million.

filing / Aug 12, 2026 / receipt

Such cost containment policies and executive orders could substantially and negatively impact the prices we may charge for any approved products, which could harm our valuation, ability to generate revenue and achieve and sustain profitability.

filing / Aug 12, 2026 / receipt

In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs.

filing / Aug 12, 2026 / receipt

Leases -As of June 30, 2026, the Company had entered into commitments under lease agreements to rent laboratory and office space and finance equipment (see Note 7).

filing / Aug 12, 2026 / receipt

, fines, settlements, investigations, criminal or civil sanctions, adverse media coverage or suspension or debarment from government contracts, all of which could damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.

filing / Aug 12, 2026 / receipt

If we are unable to successfully manage the challenges of international expansion and operations, our business and operating results could be harmed.

filing / Aug 12, 2026 / receipt

In connection with the Company’s lease of office space and laboratory space, the Company provided a security deposit to the landlord in the form of a letter of credit totaling $ 1.2 million.

filing / May 11, 2026 / receipt

Such cost containment policies and executive orders could substantially and negatively impact the prices we may charge for any approved products, which could harm our valuation, ability to generate revenue and achieve and sustain profitability.

filing / May 11, 2026 / receipt

In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs.

filing / May 11, 2026 / receipt

Leases -As of March 31, 2026, the Company had entered into commitments under lease agreements to rent laboratory and office space and finance equipment (see Note 7).

filing / May 11, 2026 / receipt

, fines, settlements, investigations, criminal or civil sanctions, adverse media coverage or suspension or debarment from government contracts, all of which could damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.

filing / May 11, 2026 / receipt

If we are unable to successfully manage the challenges of international expansion and operations, our business and operating results could be harmed.

filing / May 11, 2026 / receipt

executives
Kyle Rasbach Chief Financial Officer - receipt
Louis Tamayo Chief Financial Officer linkedin receipt
Van Hauwermeiren Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2025-08-14 Chief Financial Officer, appointed sec_8k
2024-12-19 Chief Financial Officer, appointed sec_8k
2024-07-08 Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$